Top-Rated StocksTop-RatedNASDAQ:DXCM DexCom (DXCM) Stock Price, News & Analysis $80.19 -2.33 (-2.82%) Closing price 04:00 PM EasternExtended Trading$78.88 -1.32 (-1.64%) As of 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About DexCom Stock (NASDAQ:DXCM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get DexCom alerts:Sign Up Key Stats Today's Range$79.17▼$83.0950-Day Range$77.94▼$89.5352-Week Range$56.72▼$92.59Volume4.47 million shsAverage Volume4.98 million shsMarket Capitalization$29.91 billionP/E Ratio31.45Dividend YieldN/APrice Target$95.50Consensus RatingBuy Company Overview DexCom, Inc. develops and markets continuous glucose monitoring (CGM) systems for people with diabetes. Its wearable sensors measure glucose levels throughout the day and send readings to compatible receivers or mobile devices, helping users monitor glucose trends and support treatment decisions. The company’s products include its Dexcom G6 and G7 CGM systems, along with software and connected services for users and caregivers. DexCom also offers Stelo, an over-the-counter glucose biosensor designed for adults who do not use insulin. Its CGM technology can connect with certain insulin pumps and other digital health tools. Founded in 1999 and headquartered in San Diego, California, DexCom serves customers in the United States and international markets. The company has focused on expanding access to glucose monitoring through wearable devices and connected health technology.AI Generated. May Contain Errors. Read More DexCom Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks74th Percentile Overall ScoreDXCM MarketRank™: 3.71315502183 of 5 starsDexCom scored higher than 74% of companies evaluated by MarketBeat, and ranked 341st out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingBuy Consensus RatingDexCom has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, 24 buy ratings, 2 hold ratings, and no sell ratings.Upside PotentialDexCom has a consensus price target of $95.50, representing about 19.1% upside from its current price of $80.19.Amount of Analyst CoverageDexCom has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about DexCom's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth14.93% Earnings GrowthEarnings for DexCom are expected to grow by 14.93% in the coming year, from $2.68 to $3.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DexCom is 31.45, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.67.Price to Earnings Ratio vs. SectorThe P/E ratio of DexCom is 31.45, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.85.Price to Earnings Growth RatioDexCom has a PEG Ratio of 1.36. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDexCom has a P/B Ratio of 11.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.28% of the float of DexCom has been sold short.Short Interest Ratio / Days to CoverDexCom has a short interest ratio ("days to cover") of 2.81, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in DexCom has recently increased by 1.55%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDexCom does not currently pay a dividend.Dividend GrowthDexCom does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.27 News SentimentDexCom has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for DexCom this week, compared to 9 articles on an average week.Search InterestOnly 7 people have searched for DXCM on MarketBeat in the last 30 days. This is a decrease of -42% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added DexCom to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, DexCom insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,920,193.00 in company stock.Percentage Held by Insiders0.28% of the stock of DexCom is held by insiders.Percentage Held by Institutions97.75% of the stock of DexCom is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DexCom's insider trading history. Receive DXCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DexCom and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DXCM Stock News HeadlinesDexCom Opens First Manufacturing Facility in IrelandNovember 19 at 7:07 AM | marketscreener.comMDexCom, Inc. Opens Manufacturing Facility in Athenry, County GalwayNovember 19 at 7:07 AM | marketscreener.comMThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.November 19 at 1:00 AM | Porter & Company (Ad)Dexcom Marks Athenry Opening With Celebration of Commercial Production MilestoneNovember 19 at 2:30 AM | businesswire.comDexCom, Inc. (NASDAQ:DXCM) Stock Has Consensus Price Target of $95.50 According to AnalystsNovember 19 at 1:58 AM | americanbankingnews.comDexCom, Inc. (DXCM) Presents at Jefferies Global Healthcare Conference 2026 TranscriptNovember 17 at 2:42 PM | seekingalpha.comInsider Selling: DexCom (NASDAQ:DXCM) EVP Sells 2,565 Shares of Company StockOctober 29, 2026 | insidertrades.comInsider Selling: DexCom (NASDAQ:DXCM) EVP Sells $145,316.00 in StockOctober 20, 2026 | insidertrades.comSee More Headlines DXCM Stock Analysis - Frequently Asked Questions How have DXCM shares performed this year? DexCom's stock was trading at $66.37 on January 1st, 2026. Since then, DXCM stock has increased by 20.8% and is now trading at $80.19. How were DexCom's earnings last quarter? DexCom, Inc. (NASDAQ:DXCM) issued its quarterly earnings results on Thursday, October, 29th. The medical device company reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.68 by $0.05. The company's quarterly revenue was up 11.1% compared to the same quarter last year. Read the conference call transcript. When did DexCom's stock split? DexCom's stock split on the morning of Friday, June 10th 2022.The 4-1 split was announced on Friday, March 25th 2022. The newly minted shares were distributed to shareholders after the market closes on Thursday, June 9th 2022. An investor that had 100 shares of stock prior to the split would have 400 shares after the split. Does DexCom have any subsidiaries? DexCom subsidiaries include TypeZero Technologies Inc, Nintamed Handels GmbH, DexCapital LLC, DexCom Asia Pacific Operations PTE Ltd., DexCom Canada Co, DexCom (Canada) Inc., DexCom Deutschland GmbH, and more. Who are DexCom's major shareholders? DexCom's top institutional shareholders include Stephens Investment Management Group LLC (0.34%), First Trust Advisors LP (0.27%), Sumitomo Mitsui Trust Group Inc. (0.24%) and Healthcare of Ontario Pension Plan Trust Fund (0.22%). Insiders that own company stock include Jacob Steven Leach, Kevin R Sayer, Jereme M Sylvain, Steven Robert Pacelli, Sadie Stern, Michael Jon Brown, Jon Coleman, Jon Coleman, Steven R Altman, Mark G Foletta, Matthew Vincent Dolan, Richard Alexander Collins, Nicholas Augustinos, Bridgette P Heller and Kyle Malady. View institutional ownership trends. How do I buy shares of DexCom? Shares of DXCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DexCom own? Based on aggregate information from My MarketBeat watchlists, some other companies that DexCom investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), PayPal (PYPL), Netflix (NFLX), Shopify (SHOP) and Salesforce (CRM). Company Calendar Last Earnings10/29/2026Today11/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 DXCM's financial health is in the Green zone, according to TradeSmith. DXCM has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:DXCM CIK1093557 Webwww.dexcom.com Phone(858) 200-0200Fax858-200-0201Employees11,000Year Founded1999Price Target and Rating Average Price Target for DexCom$95.50 High Price Target$120.00 Low Price Target$65.00 Potential Upside/Downside+19.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage28 Analysts Profitability EPS (Trailing Twelve Months)$2.55 Trailing P/E Ratio31.45 Forward P/E Ratio26.04 P/E Growth1.36Net Income$836.30 million Net Margins19.42% Pretax Margin24.73% Return on Equity37.77% Return on Assets15.98% Debt Debt-to-Equity Ratio0.49 Current Ratio1.74 Quick Ratio1.40 Sales & Book Value Annual Sales$5.10 billion Price / Sales5.86 Cash Flow$2.71 per share Price / Cash Flow29.63 Book Value$6.80 per share Price / Book11.79Miscellaneous Outstanding Shares372,951,000Free Float371,907,000Market Cap$29.91 billion OptionableOptionable Beta1.45 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:DXCM) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DexCom With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.